Retraction
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in Female C57BL/6
Paper Information
Record ID:
24241
Author(s):
Journal:
Publication Date:
July 01, 2014
Retraction Date:
November 01, 2020
(5.1 years years ago)
Subjects:
Institutions:
- Dept. of Neurosciences, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
- Shefa Neuroscience Research Center, Tehran, Iran
- Dept. of Pathobiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
- Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
- Dept. of Anatomical Sciences, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Country:
🇮🇷 IranArticle Type:
Publisher:
Pasteur Institute of Iran
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (11)
11
Total Citations2
Post-Retraction(18.2%)
8
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
1
After 2+ years
1359
Days since retraction (latest)
Paper citing MS14 Down-regulates Lipocalin2 Expression in Spina...
Unknown Authors
Unknown Journal
Published: Unknown
Medicinal plants used in multiple sclerosis patients, prevalence and associated factors: a descriptive cross-sectional study
Naemeh Nikvarz, Behnaz Sedighi, Mehdi Ansari et al. (6 authors)
BMC Complementary Medicine and Therapies
Open Access
Published: Jul 2024
2 citations
2 citations
1359 days after retraction
Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Doortje Dekens, Ulrich Eisel, Leonie Gouweleeuw et al. (6 authors)
Ageing Research Reviews
Open Access
Published: Jul 2021
65 citations
65 citations
267 days after retraction
A Review of Herbal Therapy in Multiple Sclerosis
Sina Mojaverrostami, Maryam Nazm Bojnordi, Maryam Ghasemi‐Kasman et al. (5 authors)
Advanced Pharmaceutical Bulletin
Open Access
Published: Nov 2018
72 citations
72 citations
703 days before retraction
Marine-derived protein kinase inhibitors for neuroinflammatory diseases
Chong Ning, Huimin Wang, Rong Gao et al. (7 authors)
BioMedical Engineering OnLine
Open Access
Published: Apr 2018
33 citations
33 citations
922 days before retraction
Remyelination modulators in multiple sclerosis patients
Rabeah Al‐Temaimi, Jehad Abubaker, Irina Al‐Khairi et al. (4 authors)
Experimental and Molecular Pathology
Published: Nov 2017
17 citations
17 citations
1089 days before retraction
Regulation and roles of CD26/DPPIV in hematopoiesis and diseases
Zeynab Aliyari Serej, Abbas Ebrahimi‐Kalan, Ahmad Mehdipour et al. (4 authors)
Biomedicine & Pharmacotherapy
Published: May 2017
32 citations
32 citations
1258 days before retraction
Ectopic Expression of Innate Immune Protein, Lipocalin-2, in Lactococcus lactis Protects Against Gut and Environmental Stressors
Piu Saha, Benoît Chassaing, Beng San Yeoh et al. (8 authors)
Inflammatory Bowel Diseases
Open Access
Published: Apr 2017
14 citations
14 citations
1285 days before retraction
The Role of Natural Products in the Prevention and Treatment of Multiple Sclerosis
Ali Shamsizadeh, Ali Roohbakhsh, Fatemeh Ayoobi et al. (4 authors)
Elsevier eBooks
Published: Jan 2017
19 citations
19 citations
1400 days before retraction
The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary
Mohammadreza Alizadeh‐Ghodsi, Ali Zavvari, Abbas Ebrahimi‐Kalan et al. (5 authors)
Nutritional Neuroscience
Published: Oct 2016
18 citations
18 citations
1489 days before retraction
An Investigation of the Retinal Layers in an Experimental Model of Multiple Sclerosis; a Histopathological and Immunohistochemical Study
Leila Roshangar, Nayyer Akbari, Amaneh Mohammadi et al. (7 authors)
British Journal of Medicine and Medical Research
Published: Jan 2016
1757 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
5.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025